PT Merck Tbk (ISX:MERK) 3-Year EBITDA Growth Rate : 21.30% (As of Jun. 2024)

View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk 3-Year EBITDA Growth Rate?

PT Merck Tbk's EBITDA per Share for the three months ended in Jun. 2024 was Rp76.77.

During the past 12 months, PT Merck Tbk's average EBITDA Per Share Growth Rate was -25.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 31.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Merck Tbk was 115.80% per year. The lowest was -67.60% per year. And the median was 14.00% per year.

Competitive Comparison of PT Merck Tbk's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Merck Tbk's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's 3-Year EBITDA Growth Rate falls into.

PT Merck Tbk 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PT Merck Tbk (ISX:MERK) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PT Merck Tbk 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Merck Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760

Website

https://www.merck.co.id

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines